Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Mimedx (MDXG) over the last 15 years, with Q3 2025 value amounting to 0.22%.

  • Mimedx's Return on Capital Employed fell 1100.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.29% for FY2024, which is 500.0% up from last year.
  • Mimedx's Return on Capital Employed amounted to 0.22% in Q3 2025, which was down 1100.0% from 0.19% recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Return on Capital Employed peaked at 0.34% during Q2 2024, and registered a low of 0.27% during Q1 2021.
  • Over the past 5 years, Mimedx's median Return on Capital Employed value was 0.12% (recorded in 2023), while the average stood at 0.06%.
  • In the last 5 years, Mimedx's Return on Capital Employed soared by 4400bps in 2023 and then crashed by -1500bps in 2025.
  • Over the past 5 years, Mimedx's Return on Capital Employed (Quarter) stood at 0.05% in 2021, then plummeted by -130bps to 0.11% in 2022, then soared by 293bps to 0.22% in 2023, then grew by 28bps to 0.28% in 2024, then fell by -23bps to 0.22% in 2025.
  • Its last three reported values are 0.22% in Q3 2025, 0.19% for Q2 2025, and 0.24% during Q1 2025.